INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Jan 06, 2012 |
Director, EVP, CSO & Pres, REGN Res Labs
Trans History: 617
|
Director, EVP, CSO & Pres, REGN Res Labs | Form 4 | Other acquisition or disposition | -- | -- | 5,390 |
Dec 20, 2011 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Other acquisition or disposition | -- | -- | 5,416 |
Dec 20, 2011 |
VP Regulatory Development and
Trans History: 288
|
VP Regulatory Development and | Form 4 | Other acquisition or disposition | -- | -- | 1,200 |
Dec 20, 2011 |
VP Regulatory Development and
Trans History: 288
|
VP Regulatory Development and | Form 4 | Other acquisition or disposition | -- | -- | 4,187 |
Dec 20, 2011 |
VP Regulatory Development and
Trans History: 288
|
VP Regulatory Development and | Form 4 | Other acquisition or disposition | -- | -- | 1,200 |
Dec 20, 2011 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 84,773 |
Dec 20, 2011 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Other acquisition or disposition | -- | -- | 5,416 |
Dec 15, 2011 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Other acquisition or disposition | -- | -- | 5,416 |
Dec 15, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,335 |
Dec 15, 2011 |
Director, EVP CSO President Regeneron Re
Trans History: 617
|
Director, EVP CSO President Regeneron Re | Form 4 | Other acquisition or disposition | -- | -- | 5,390 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.